Charles River Laboratories International Inc (NYSE:CRL)
$ 232.82 4.41 (1.93%) Market Cap: 11.99 Bil Enterprise Value: 14.52 Bil PE Ratio: 27.33 PB Ratio: 3.29 GF Score: 96/100

Q4 2023 Charles River Laboratories International Inc Earnings Call Transcript

Feb 14, 2024 / 01:30PM GMT
Release Date Price: $245.12 (+11.30%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories Fourth Quarter and Full Year 2023 Earnings Conference Call. This call is being recorded.

(Operator Instructions)

I would now like to turn the conference over to our host, Todd Spencer, Vice President of Investor Relations. Please go ahead.

Todd Spencer
Charles River Laboratories International, Inc. - Corporate VP of IR

Good morning, and welcome to Charles River Laboratories Fourth Quarter and Full Year 2023 Earnings and 2024 Guidance Conference Call and Webcast. This morning, I am joined by Jim Foster, Chairman, President and Chief Executive Officer; and Flavia Pease, Executive Vice President and Chief Financial Officer. They will comment on our results for the fourth quarter of '23 as well as our financial guidance for 2024.

Following the presentation, they will respond to questions. There is a slide presentation associated with today's remarks, which is posted on the Investor Relations section of our website at ir.criver.com. A webcast

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot